MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

Search

AngioDynamics Inc

Открыт

СекторЗдравоохранение

9.49 -1.04

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

9.13

Макс.

9.68

Ключевые показатели

By Trading Economics

Доход

6.3M

-4.4M

Продажи

-841K

72M

Прибыль на акцию

-0.08

Рентабельность продаж

-6.12

Сотрудники

748

EBITDA

-2.1M

-329K

Рекомендации

By TipRanks

Рекомендации

Покупка

Прогноз на 12 месяцев

+65.78% upside

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-8.8M

376M

Предыдущая цена открытия

10.53

Предыдущая цена закрытия

9.49

Техническая оценка

By Trading Central

Уверенность

Strong Bullish Evidence

AngioDynamics Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

9 дек. 2024 г., 15:23 UTC

Главные движущие силы рынка

AngioDynamics Shares at 52-Week High After FDA Clears NanoKnife

9 дек. 2024 г., 15:20 UTC

Главные движущие силы рынка

AngioDynamics Shares at 52-Week High After FDA Clears NanoKnife

Сравнение c конкурентами

Изменение цены

AngioDynamics Inc Прогноз

Целевая цена

By TipRanks

65.78% рост

Прогноз на 12 месяцев

Средняя 15.5 USD  65.78%

Максимум 16 USD

Минимум 15 USD

Основано на мнении 2 аналитиков Wall Street, спрогнозировавших целевые цены для AngioDynamics Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

2 ratings

2

Покупка

0

Удержание

0

Продажа

Техническая оценка

By Trading Central

9.4553 / 9.76Поддержка и Сопротивление

Краткосрочная

Strong Bullish Evidence

Среднесрочная

Strong Bearish Evidence

Долгосрочная

Weak Bullish Evidence

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании AngioDynamics Inc

AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.